Controlling false discovery proportion in identification of drug-related adverse events from multiple system organ classes
From MaRDI portal
Publication:6628702
DOI10.1002/SIM.8304zbMATH Open1546.62741MaRDI QIDQ6628702
Joseph G. Ibrahim, William S-Y Wang, Donglin Zeng, [[Person:6056149|Author name not available (Why is that?)]], Guoqing Diao, Joseph F. Heyse, Xianming Tan
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Could not fetch data.
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Title not available (Why is that?)
- Estimating the proportion of false null hypotheses among a large number of independently tested hypotheses
- Control of the false discovery proportion for independently tested null hypotheses
- Stepup procedures for control of generalizations of the familywise error rate
- Controlling the number of false discoveries: application to high-dimensional genomic data
- A stochastic process approach to false discovery control.
- False Discovery Control for Multiple Tests of Association Under General Dependence
- Hierarchical False Discovery Rate–Controlling Methodology
- Miscellanea. A note on generating correlated binary variables
- False Discovery Control for Random Fields
- False Discovery Rate Control With Groups
- Use of the false discovery rate for evaluating clinical safety data
This page was built for publication: Controlling false discovery proportion in identification of drug-related adverse events from multiple system organ classes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628702)
